Legend Biotech (LEGN) Payables (2021 - 2025)

Legend Biotech (LEGN) has reported Payables for 5 consecutive years, with $83.0 million the latest figure, recorded in Q4 2025.

• Payables for Q4 2025 came in at $83.0 million, up 115.03% year-over-year; the trailing twelve-month figure through Dec 2025 was $83.0 million (up 115.03% YoY), and the FY2025 annual result was $83.0 million, up 115.03% from the prior year.
• Payables was $83.0 million for Q4 2025 at Legend Biotech, down from $102.5 million in the prior quarter.
• Over five years, Payables peaked at $102.5 million in Q3 2025 and troughed at $7.0 million in Q4 2021.
• Average Payables over 5 years is $40.8 million, with a median of $32.9 million recorded in 2022.
• Year-over-year, Payables surged 367.03% in 2022 and slipped 6.8% in 2023.
• Over 5 years, Payables stood at $7.0 million in 2021, then soared by 367.03% to $32.9 million in 2022, then dropped by 6.8% to $30.7 million in 2023, then increased by 25.92% to $38.6 million in 2024, then soared by 115.03% to $83.0 million in 2025.
• Per Business Quant data, the three most recent Payables figures were $83.0 million in Q4 2025, $102.5 million in Q3 2025, and $75.4 million in Q2 2025.